✦ LIBER ✦

Tyrosine Kinase Inhibitors in Preclinical Development

✍ Scribed by Mark L. Levitt; Patrick P. Koty

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of inhibitors for protein ty

✍ Al-Obeidi, Fahad A; Lam, Kit S 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 260 KB

Clinical development of EGFR-tyrosine ki

✍ Kazuhiko Nakagawa 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 268 KB

FLT3 Tyrosine Kinase Inhibitors

✍ Mark Levis; Donald Small 📂 Article 📅 2005 🏛 Carden Jennings Publishing 🌐 English ⚖ 104 KB

Tyrosine kinase inhibitors in cancer the

✍ Srinivasan Madhusudan; Trivadi S. Ganesan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 518 KB

Development of Second-Generation VEGFR T

✍ Pankaj Bhargava; Murray O. Robinson 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 289 KB

Development of pyrimidine-based inhibito

✍ Jack J. Chen; Kumar D. Thakur; Michael P. Clark; Steven K. Laughlin; Kelly M. Ge 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 165 KB